The Current Ratio as of December 2025 (TTM) for GeneTether Therapeutics Inc. (GTTX.CN) is 34.52

According to GeneTether Therapeutics Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 34.52. This represents a change of -2.40% compared to the average of 35.37 of the last 4 quarters.

GeneTether Therapeutics Inc. (GTTX.CN) Historical Current Ratio (quarterly & annually)

How has GTTX.CN Current Ratio performed in the past?

The mean historical Current Ratio of GeneTether Therapeutics Inc. over the last ten years is 12.30. The current 34.52 Current Ratio has changed 27.96% with respect to the historical average. Over the past ten years (40 quarters), GTTX.CN's Current Ratio was at its highest in in the September 2023 quarter at 47.92. The Current Ratio was at its lowest in in the March 2021 quarter at 0.

GeneTether Therapeutics Inc. (GTTX.CN) Current Ratio by Quarter and Year

Discovering the peaks and valleys of GeneTether Therapeutics Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

GeneTether Therapeutics Inc. (GTTX.CN) Average Current Ratio

How has GTTX.CN Current Ratio performed in the past?

The current Current Ratio of GeneTether Therapeutics Inc. (GTTX.CN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

GeneTether Therapeutics Inc. (GTTX.CN) Current Ratio vs. Peers

How is GTTX.CN’s Current Ratio compared to its peers?

GeneTether Therapeutics Inc.’s Current Ratio is greater than Clearmind Medicine Inc. (1.74), greater than Awakn Life Sciences Corp. (0.40), greater than Asep Medical Holdings Inc (0.04), greater than Tryp Therapeutics Inc. (0.24), greater than Bhang Inc. (1.22), greater than Heritage Cannabis Holdings Corp. (1.28), greater than 4Front Ventures Corp. (0.34), greater than MYND Life Sciences Inc. (0.14), greater than StageZero Life Sciences Ltd. (0.02), greater than The BC Bud Corporation (1.87),

Build a custom stock screener for GeneTether Therapeutics Inc. (GTTX.CN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like GeneTether Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

GeneTether Therapeutics Inc. (GTTX.CN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like GeneTether Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.